KOMP - ETF AI Analysis
Top Page
SPDR S&P Kensho New Economies Composite ETF (KOMP)
KOMP, the SPDR S&P Kensho New Economies Composite ETF, has a solid but not top-tier rating, reflecting a mix of strong innovators and more challenged names. Leaders like Nvidia and PTC support the fund’s quality with strong financial performance, positive earnings outlooks, and strategic focus on AI and advanced technologies, while holdings such as Twist Bioscience, 3D Systems, and Ouster weigh on the rating due to profitability issues, weak technical trends, and operational challenges. The main risk is that many holdings are in high-growth, tech-focused areas where valuations, profitability, and macroeconomic pressures can create volatility.
KOMP vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.46B
- Region
- Global
- Expense Ratio
- 0.20%
- Beta
- 1.31
- Issuer
- SPDR
- Inception Date
- Oct 22, 2018
- Dividend Yield
- 1.62%
- Asset Class
- Equity
- Index Tracked
- S&P Kensho New Economies Composite Index
KOMP Summary
KOMP is an ETF that follows the S&P Kensho New Economies Composite Index, focusing on companies shaping the future economy. It invests in areas like robotics, artificial intelligence, clean energy, and advanced manufacturing, with most holdings based in the United States. The fund owns innovative companies such as 3D Systems and Bruker, giving investors a way to spread their money across many cutting-edge businesses instead of picking just one stock. Someone might invest in KOMP for long-term growth and diversification into new technologies. A key risk is that these innovative sectors can be volatile, so the ETF’s value can rise and fall sharply with market conditions.
How much will it cost me?
The SPDR S&P Kensho New Economies Composite ETF (KOMP) has an expense ratio of 0.20%, meaning you’ll pay $2 per year for every $1,000 invested. This is lower than average for actively managed funds, as KOMP tracks an index focused on innovative sectors rather than requiring frequent adjustments by fund managers.
What would affect this ETF?
KOMP's focus on innovative sectors like robotics, artificial intelligence, and clean energy positions it to benefit from growing demand for technological advancements and sustainability initiatives globally. However, its reliance on high-growth industries makes it sensitive to economic slowdowns, rising interest rates, or regulatory changes that could impact funding and innovation in these areas.
KOMP Top 10 Holdings
KOMP is leaning into the “new economy” story, with innovative names doing most of the heavy lifting. Twist Bioscience has been rising steadily, giving the fund a boost from the cutting-edge biotech side, while 3D Systems is still lagging as it works through revenue and profitability issues. Unity Software and Ambarella show mixed signals—promising tech and AI exposure, but choppy stock action that can tug on returns. With a clear tilt toward technology and industrial innovation and a global mix of holdings, KOMP is a diversified bet on future-focused growth themes.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 TWST | Twist Bioscience | 1.58% | $39.10M | $9.20B | 335.86% | 43Neutral |
 PTC | PTC | 1.44% | $35.53M | $20.97B | -6.08% | 73Outperform |
 DDD | 3D Systems | 1.21% | $29.85M | $495.12M | -21.16% | 44Neutral |
 U | Unity Software | 1.04% | $25.85M | $17.67B | 13.86% | 65Neutral |
 BRKR | Bruker | 1.03% | $25.54M | $8.52B | 46.76% | 63Neutral |
 IL:ESLT | Elbit Systems | 1.07% | $26.49M | ILS 109.62B | 46.38% | 73Outperform |
 HIMX | Himax Technologies | 0.96% | $23.72M | $2.04B | 24.47% | 69Neutral |
 AMBA | Ambarella | 0.88% | $21.84M | $2.79B | -25.17% | 59Neutral |
 META | Meta Platforms | 0.83% | $20.61M | $1.80T | -5.18% | 76Outperform |
 NVDA | Nvidia | 0.84% | $20.83M | $5.23T | 18.52% | 76Outperform |
KOMP Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For KOMP, the sentiment is Negative. The current price of 62.93 is below the 20-day moving average (MA) of 65.76, below the 50-day MA of 67.11, and below the 200-day MA of 65.86, indicating a bearish trend. The MACD of -1.21 indicates Positive momentum. The RSI at 36.82 is Neutral, neither overbought nor oversold. The STOCH value of 13.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KOMP.
KOMP Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| KOMP | $62.93 | $70.00(11.23% Upside) | $2.46B | 0.20% | 61Neutral |
 GUNR | $54.29 | $60.62(11.67% Upside) | $7.12B | 0.46% | 59Neutral |
 GNR | $76.47 | $85.83(12.25% Upside) | $5.43B | 0.40% | 64Neutral |
 ARKG | $48.65 | $64.17(31.90% Upside) | $2.10B | 0.75% | 53Neutral |
 FWD | $123.65 | $157.86(27.66% Upside) | $3.26B | 0.65% | 64Neutral |
 SQS | $27.77 | $35.26(26.97% Upside) | $1.38B | 0.80% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KOMP | SPDR S&P Kensho New Economies Composite ETF | 62.93 | 1.10 | 1.78% | |
| GUNR | FlexShares Morningstar Global Upstream Natural Resources Index Fund | 54.29 | 11.89 | 28.06% | |
| GNR | SPDR S&P Global Natural Resources ETF | 76.47 | 19.45 | 34.10% | |
| ARKG | ARK Genomic Revolution ETF | 48.65 | 18.08 | 59.14% | |
| FWD | AB Disruptors ETF | 123.65 | 21.00 | 20.46% | |
| SQS | Sapient Quality Select ETF | 27.77 | 2.46 | 9.70% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.